Enfermedad hepática esteatósica asociada a disfunción metabólica y síndrome CKM

Ma et al. (jueves,) estudiaron esta cuestión.

www.synapsesocial.com/papers/69fd56229d16c71bcbe22335 — DOI: https://doi.org/10.1016/j.jacc.2025.12.007

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Hepatic steatosis in cardiovascular–kidney–metabolic syndrome: fatty liver Index as a predictor of cardiovascular outcomes· 2025 · 9 citations
2. Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States· 2025 · 8 citations
3. Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)· 2025 · 5 citations
4. The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists· 2025 · 9 citations
5. Incorporation of Metabolic Dysfunction‐Associated Steatotic Liver Disease in the Health Stage of Cardiovascular‐Kidney‐Metabolic Syndrome Improves Predictive Ability for Coronary Artery Disease in a Japanese General Population· 2025 · 11 citations